Kristin Hodous | Senior Manager, IR |
Jeff Albers | CEO |
Andy Boral | CMO |
Marion Dorsch | CSO |
Mike Landsittel | VP, Finance |
Terence Flynn | Goldman Sachs |
Andrew Berens | Leerink Partners |
Joseph Thorne | Cowen & Company |
Laura Chico | Raymond James |
Arlinda Lee | Canaccord |
Konstantinos Aprilakis | JMP Securities |
Eun Yang | Jefferies |
Good day, ladies and gentlemen, and welcome to the Blueprint Medicines Third Quarter 2018 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference is being recorded.